Our Pharma Insights Blog
When filing an NCE-1 application, being the first applicant to do so is not just…
2028 is going to be a landmark year in the pharmaceutical industry. Several blockbuster drugs,…
After two decades in pharma, one thing stands out time and again: timing is everything—and…
The Promise of Healing Without Medicines Imagine a situation wherein, instead of treating diseases with…
Spring Bio Solution is a global leader in comparator sourcing and clinical trial supplies. We have created NCE Grid to simplify…
All pharmaceutical companies today are racing to bring new treatments to market as quickly as…
In the journey of pharmaceutical development, strategic comparator sourcing has emerged as a critical factor…
Clinical trial supply management (CTSM) involves all the processes, such as planning, forecasting, procurement, manufacturing,…
We often hear this common concern from clinical trial managers: “We need a comparator drug…
Blood cancer affects millions of people worldwide, creating a challenging situation. A study predicts that in 2025, 66,890 new cancer cases and 23,540 cancer deaths will occur in the United States due to leukemia.
Recently, a few clinical trial sponsors approached us because they were facing a challenge in distinguishing between a genuine and counterfeit pack of an Immuno-Oncology Drug.
Decentralized Clinical Trials (DCTs) have transformed how clinical trials are conducted. This makes the clinical…